Inactivating mutations in the tumour suppressor gene VHL have been associated with several diseases, including pheochromocytoma, erythrocytosis, renal cell carcinoma, and cerebellar hemangioblastoma [50]. This evidence concerns the gene VHL and hereditary clear cell renal cell carcinoma.